Depressive Disorders: Mechanisms, Measurement and Management (Advances in Experimental Medicine and Biology) 1st ed. 2019 Edition
by
Product Details
|

Signup for our newsletter to get notified about sales and new products. Add any text here or remove it.
NEJM – One year
Mechanical Ventilation in Emergency Medicine
Anatomy and Examination in Ocular Trauma
Sanford Guide (APP) – Two Year
Advances in Psychiatry 1st ed. 2019 Edition
The Ileoanal Pouch: A Practical Guide for Surgery, Management and Troubleshooting 1st ed. 2019 Edition
Posterior Hip Disorders: Clinical Evaluation and Management 1st ed. 2019 Edition
NEJM – One year
Mechanical Ventilation in Emergency Medicine
Anatomy and Examination in Ocular Trauma
Sanford Guide (APP) – Two Year
Advances in Psychiatry 1st ed. 2019 Edition
The Ileoanal Pouch: A Practical Guide for Surgery, Management and Troubleshooting 1st ed. 2019 Edition
Posterior Hip Disorders: Clinical Evaluation and Management 1st ed. 2019 Edition 18 $
Delivery time: Maximum to 1 hours
by Yiru Fang (Editor)
by Yiru Fang (Editor)
This book offers a state-of-the-art report on recent discoveries concerning the basic and clinical, neuroscientific and psychiatric findings in depression research. Depressive disorder is a severe and recurrent brain disorder that can manifest in depressive mood, somatic symptoms and cognitive impairment. The underlying mechanisms of depressive disorder and its clinical practice are subjects of long-standing interests. This book is a biologically plausible and multilevel theory which describes neural, physiological, molecular and genomic mechanisms that drive depression pathogenesis, as well as navigates the clinical practice and management for depressive disorder. It mainly describes advances made over the past 20 years on the neural, molecular, neuroimaging, physiology, pathophysiology, pharmacology and internet-based measurement and management of depressive disorder. It will help postgraduate students and academic researchers to get either basic or clinical picture of depressive disorder. Also, it may benefit pharmaceutical companies for developing novel drugs to treat this disease.
Product Details
|